You are using an unsupported browser. Please upgrade your browser to a newer version to get the best experience on DrugBank.
Identification
NameRanitidine
Accession NumberDB00863  (APRD00254)
TypeSmall Molecule
GroupsApproved
Description

A non-imidazole blocker of those histamine receptors that mediate gastric secretion (H2 receptors). It is used to treat gastrointestinal ulcers. [PubChem]

Structure
Thumb
Synonyms
RAN
Ranitidina
Ranitidinum
External Identifiers Not Available
Prescription Products
NameDosageStrengthRouteLabellerMarketing StartMarketing End
Acid Reducertablet150 mgoralPendopharm Division Of De Pharmascience IncNot applicableNot applicableCanada
Act Ranitidinetablet300 mgoralActavis Pharma Company2004-02-19Not applicableCanada
Act Ranitidinetablet150 mgoralActavis Pharma Company2004-04-19Not applicableCanada
Bci Ranitidinetablet300 mgoralBaker Cummins IncNot applicableNot applicableCanada
Bci Ranitidinetablet150 mgoralBaker Cummins IncNot applicableNot applicableCanada
Dom-ranitidinetablet300 mgoralDominion Pharmacal2001-03-22Not applicableCanada
Dom-ranitidinetablet150 mgoralDominion Pharmacal2001-03-22Not applicableCanada
Ipg-ranitidinetablet300 mgoralInternational Pharmaceutical Generics LtdNot applicableNot applicableCanada
Ipg-ranitidinetablet150 mgoralInternational Pharmaceutical Generics LtdNot applicableNot applicableCanada
Med Ranitidine Tablets 150mgtablet150 mgoralMedican Pharma Incorporated1999-04-062011-03-29Canada
Myl-ranitidinetablet300 mgoralMylan Pharmaceuticals Ulc2011-05-13Not applicableCanada
Myl-ranitidinetablet150 mgoralMylan Pharmaceuticals Ulc2011-05-13Not applicableCanada
Mylan-ranitidinetablet300 mgoralMylan Pharmaceuticals Ulc1996-12-31Not applicableCanada
Mylan-ranitidinetablet150 mgoralMylan Pharmaceuticals Ulc1996-12-31Not applicableCanada
Nu-ranit Tab 150mgtablet150 mgoralNu Pharm Inc1990-12-312012-09-04Canada
Nu-ranit Tab 300mgtablet300 mgoralNu Pharm Inc1990-12-312012-09-04Canada
PHL-ranitidinetablet300 mgoralPharmel Inc2002-08-27Not applicableCanada
PHL-ranitidinetablet150 mgoralPharmel Inc2002-08-27Not applicableCanada
PMS-ranitidine 150 mgtablet150 mgoralPharmascience Inc2000-08-25Not applicableCanada
PMS-ranitidine 300 mgtablet300 mgoralPharmascience Inc2000-08-25Not applicableCanada
Pyloridtablet400 mgoralGlaxo Wellcome Inc.1997-08-292000-07-27Canada
Ran-ranitidinetablet150 mgoralRanbaxy Pharmaceuticals Canada Inc.2009-11-02Not applicableCanada
Ran-ranitidinetablet300 mgoralRanbaxy Pharmaceuticals Canada Inc.2009-11-02Not applicableCanada
Ranitidinetablet300 mgoralSanis Health Inc2010-07-26Not applicableCanada
Ranitidinetablet150 mgoralCobalt Pharmaceuticals CompanyNot applicableNot applicableCanada
Ranitidinetablet150 mgoralMylan Pharmaceuticals Ulc2009-10-222012-10-19Canada
Ranitidinetablet150 mgoralSanis Health Inc2010-07-26Not applicableCanada
Ranitidinetablet300 mgoralSivem Pharmaceuticals Ulc2012-06-11Not applicableCanada
Ranitidinetablet150 mgoralSivem Pharmaceuticals Ulc2012-06-11Not applicableCanada
Ranitidinetablet300 mgoralSorres Pharma Inc2009-06-222014-06-20Canada
Ranitidinetablet150 mgoralSorres Pharma Inc2009-06-222014-06-20Canada
Ranitidinetablet300 mgoralCobalt Pharmaceuticals CompanyNot applicableNot applicableCanada
Ranitidinetablet300 mgoralMylan Pharmaceuticals Ulc2009-10-222012-10-19Canada
Ranitidine - 150tablet150 mgoralPro Doc Limitee1988-12-31Not applicableCanada
Ranitidine - 300tablet300 mgoralPro Doc Limitee1988-12-31Not applicableCanada
Ranitidine Injection USPsolution25 mgintramuscular; intravenousSandoz Canada Incorporated2004-09-16Not applicableCanada
Ranitidine Tabletstablet300 mgoralRanbaxy Pharmaceuticals Canada Inc.Not applicableNot applicableCanada
Ranitidine Tabletstablet150 mgoralRanbaxy Pharmaceuticals Canada Inc.Not applicableNot applicableCanada
Ranitidine Tablets 150mgtablet150 mgoralPrempharm Inc1997-01-032005-08-05Canada
Ranitidine Tablets 300mgtablet300 mgoralPrempharm Inc1997-01-032005-08-05Canada
Ratio-ranitidinetablet300 mgoralRatiopharm Inc Division Of Teva Canada Limited1989-12-312014-09-19Canada
Ratio-ranitidinetablet150 mgoralRatiopharm Inc Division Of Teva Canada Limited1989-12-312014-09-19Canada
Riva-ranitidine 150tablet150 mgoralLaboratoire Riva Inc2005-07-05Not applicableCanada
Riva-ranitidine 300tablet300 mgoralLaboratoire Riva Inc2005-07-11Not applicableCanada
Sandoz Ranitidinetablet150 mgoralSandoz Canada Incorporated2001-05-15Not applicableCanada
Sandoz Ranitidinetablet300 mgoralSandoz Canada Incorporated2001-05-15Not applicableCanada
Scheinpharm Ranitidine 150 mgtablet150 mgoralPharmascience Inc2000-04-252014-09-08Canada
Scheinpharm Ranitidine 300 mgtablet300 mgoralPharmascience Inc2000-04-252014-09-08Canada
Teva-ranitidinetablet150 mgoralTeva Canada Limited1989-12-31Not applicableCanada
Teva-ranitidinetablet300 mgoralTeva Canada Limited1989-12-31Not applicableCanada
Teva-ranitidine Injectionsolution25 mgintramuscular; intravenousTeva Canada LimitedNot applicableNot applicableCanada
Teva-ranitidine Solutionsolution15 mgoralTeva Canada Limited2004-09-08Not applicableCanada
Tria-ranitidine 150mg Tablettablet150 mgoralLaboratoires Trianon IncNot applicableNot applicableCanada
Tria-ranitidine 300mg Tablettablet300 mgoralLaboratoires Trianon IncNot applicableNot applicableCanada
Zantactablet150 mgoralGlaxosmithkline Inc1999-08-06Not applicableCanada
Zantactablet, film coated150 mg/1oralGlaxo Smith Kline Llc1989-10-012016-04-23Us
Zantacsolution15 mgoralGlaxosmithkline Inc1998-10-272012-02-29Canada
Zantacliquid25 mgintramuscular; intravenousGlaxo Canada Inc1984-12-312001-10-26Canada
Zantacinjection, solution25 mg/mLintramuscular; intravenousCardinal Health1989-10-012016-04-05Us
Zantacinjection, solution25 mg/mLintramuscular; intravenousCovis Pharmaceuticals, Inc.2013-06-142016-04-05Us
Zantacinjection, solution25 mg/mLintramuscular; intravenousCovis Pharmaceuticals, Inc.2013-06-142016-04-05Us
Zantacsolution25 mgintramuscular; intravenousGlaxosmithkline Inc2000-05-01Not applicableCanada
Zantacinjection, solution25 mg/mLintramuscular; intravenousCovis Pharmaceuticals, Inc.2013-03-152016-04-05Us
Zantactablet300 mgoralGlaxosmithkline Inc1999-12-20Not applicableCanada
Zantactablet, film coated300 mg/1oralGlaxo Smith Kline Llc1989-10-012016-04-23Us
Zantac Oral Solution 15mg/mlsolution15 mgoralGlaxo Canada Inc1989-12-311999-08-12Canada
Zantac Tab 150mgtablet150 mgoralGlaxo Canada Inc1982-12-312000-08-02Canada
Zantac Tab 300mgtablet300 mgoralGlaxo Canada Inc1986-12-312000-08-02Canada
Zantac-C Cap 150mgcapsule150 mgoralGlaxo Canada Inc1990-12-311998-07-30Canada
Zantac-C Cap 300mgcapsule300 mgoralGlaxo Canada Inc1990-12-311998-07-30Canada
Generic Prescription Products
NameDosageStrengthRouteLabellerMarketing StartMarketing End
Apo-ranitidinesolution15 mgoralApotex Inc2006-07-14Not applicableCanada
Apo-ranitidine Tablet 150mgtablet150 mgoralApotex Inc1987-12-31Not applicableCanada
Apo-ranitidine Tablet 300mgtablet300 mgoralApotex Inc1987-12-31Not applicableCanada
Good Sense Acid Reducertablet75 mg/1oralbryant ranch prepack2009-05-212016-04-05Us
Ranitidinetablet150 mg/1oralNorthwind Pharmaceuticals, LLC2014-09-152016-04-05Us
Ranitidinetablet300 mg/1oralPar Pharmaceutical Inc1999-01-282016-04-05Us
Ranitidinetablet150 mg/1oralCardinal Health2009-12-162016-04-05Us
Ranitidinetablet300 mg/1oralMajor Pharmaceuticals2010-07-232016-04-05Us
Ranitidinetablet300 mg/1oralSTAT Rx USA LLC1998-12-172016-04-05Us
Ranitidinetablet150 mg/1oralState of Florida DOH Central Pharmacy2009-07-012016-04-05Us
Ranitidinetablet, film coated150 mg/1oralNcs Health Care Of Ky, Inc Dba Vangard Labs2009-11-062016-04-23Us
Ranitidinetablet150 mg/1oralClinical Solutions Wholesale2009-12-162016-04-05Us
Ranitidinetablet, film coated150 mg/1oralREMEDYREPACK INC.2013-03-262016-04-05Us
Ranitidinesolution15 mg/mLoralPharmaceutical Associates, Inc.2009-09-192016-04-23Us
Ranitidinetablet300 mg/1oralAv Kare, Inc.2014-08-182016-04-05Us
Ranitidinetablet150 mg/1oralWockhardt Limited2009-12-112016-04-05Us
Ranitidinesyrup15 mg/mLoralWOCKHARDT USA LLC2009-05-262016-04-05Us
Ranitidinetablet300 mg/1oralCardinal Health2009-12-162016-04-05Us
Ranitidinetablet150 mg/1oralBlenheim Pharmacal, Inc.2011-09-302016-04-05Us
Ranitidinetablet, film coated150 mg/1oralProficient Rx LP2008-11-192016-04-05Us
Ranitidinesolution15 mg/mLoralCarilion Materials Management2010-12-102016-04-05Us
Ranitidinetablet, film coated150 mg/1oralApotex Corp1997-09-132016-04-05Us
Ranitidinetablet150 mg/1oralContract Pharmacy Services Pa2010-03-112016-04-05Us
Ranitidinetablet300 mg/1oralWockhardt USA LLC.2009-12-112016-04-05Us
Ranitidinetablet150 mg/1oralAmerican Health Packaging2012-03-012015-12-30Us
Ranitidinesyrup15 mg/mLoralDr. Reddy's Laboratories Limited2009-05-262016-04-05Us
Ranitidinetablet150 mg/1oralMajor Pharmaceuticals2010-07-232016-04-05Us
Ranitidinetablet150 mg/1oralState of Florida DOH Central Pharmacy2009-07-012016-04-05Us
Ranitidinetablet, film coated300 mg/1oralClinical Solutions Wholesale2008-11-192016-04-05Us
Ranitidinetablet150 mg/1oralAv Kare, Inc.2014-08-182016-04-05Us
Ranitidinetablet, film coated300 mg/1oralPd Rx Pharmaceuticals, Inc.2009-11-062016-04-05Us
Ranitidinetablet300 mg/1oralRebel Distributors2009-12-172016-04-05Us
Ranitidinetablet150 mg/1oralWockhardt USA LLC.2009-12-112016-04-05Us
Ranitidinetablet300 mg/1oralDIRECT RX2014-01-012016-04-05Us
Ranitidinetablet150 mg/1oralCarilion Materials Management2009-12-162016-04-05Us
Ranitidinetablet, film coated150 mg/1oralMed Vantx, Inc.1997-09-122016-04-05Us
Ranitidinetablet, film coated150 mg/1oralMc Kesson Contract Packaging2011-10-262016-04-05Us
Ranitidinetablet, film coated300 mg/1oralUnit Dose Services2008-11-192016-04-05Us
Ranitidinesyrup15 mg/mLtopicalSandoz Inc.2011-10-252020-10-25Us
Ranitidinetablet, film coated150 mg/1oralState of Florida DOH Central Pharmacy2009-07-012016-04-05Us
Ranitidinesolution75 mg/5mLoralQualitest Pharmaceuticals2010-07-012016-04-23Us
Ranitidinetablet, film coated150 mg/1oralClinical Solutions Wholesale2008-11-192016-04-05Us
Ranitidinetablet150 mg/1oralLake Erie Medical DBA Quality Care Products LLC2009-12-162016-04-05Us
Ranitidinetablet150 mg/1oralPd Rx Pharmaceuticals, Inc.2009-12-162016-04-05Us
Ranitidinetablet150 mg/1oralRebel Distributors2009-12-172016-04-05Us
Ranitidinetablet150 mg/1oralMc Kesson Packaging Services Business Unit Of Mc Kesson Corporation2012-11-062016-04-05Us
Ranitidinesyrup15 mg/mLoralAurobindo Pharma Limited2010-07-282016-04-05Us
Ranitidinetablet150 mg/1oralPreferred Pharmaceuticals, Inc2012-02-272016-04-05Us
Ranitidinetablet, film coated150 mg/1oralUnit Dose Services2008-11-192016-04-05Us
Ranitidinetablet300 mg/1oralAmneal Pharmaceuticals of New York, LLC2009-12-162016-04-05Us
Ranitidinesolution15 mg/mLoralActavis Mid Atlantic LLC2007-03-152016-04-23Us
Ranitidinesyrup15 mg/mLoralSun Pharmaceutical Industries, Inc.2011-10-032016-04-05Us
Ranitidinetablet150 mg/1oralRx Change Co.2014-11-252016-04-05Us
Ranitidinetablet, film coated150 mg/1oralCardinal Health2009-11-062016-03-11Us
Ranitidinesolution15 mg/mLoralAtlantic Biologicals Corps2010-03-122016-04-05Us
Ranitidinetablet150 mg/1oralMc Kesson Packaging Services Business Unit Of Mc Kesson Corporation2004-07-012016-04-05Us
Ranitidinetablet150 mg/1oralREMEDYREPACK INC.2015-07-222016-04-05Us
Ranitidinesolution15 mg/mLoralSilarx Pharmaceuticals, Inc.2010-12-102016-04-05Us
Ranitidinetablet300 mg/1oralPreferred Pharmaceuticals, Inc2012-02-272016-04-05Us
Ranitidinesyrup15 mg/mLoralUnit Dose Services2013-07-152016-04-05Us
Ranitidinetablet150 mg/1oralREMEDYREPACK INC.2010-12-062016-04-05Us
Ranitidinesolution150 mg/mLoralPhysicians Total Care, Inc.2007-10-032016-04-05Us
Ranitidinetablet150 mg/1oralAmneal Pharmaceuticals of New York, LLC2009-12-162016-04-05Us
Ranitidinetablet150 mg/1oralLiberty Pharmaceuticals, Inc.2009-12-162016-04-23Us
Ranitidinetablet300 mg/1oralWockhardt Limited1998-12-172016-04-05Us
Ranitidinetablet300 mg/1oralAidarex Pharmaceuticals LLC2009-12-162016-04-05Us
Ranitidinetablet300 mg/1oralSTAT Rx USA LLC2009-12-162016-04-05Us
Ranitidinetablet, film coated75 mg/1oralREMEDYREPACK INC.2015-03-092016-04-05Us
Ranitidinetablet300 mg/1oralLake Erie Medical DBA Quality Care Products LLC2009-12-162016-04-05Us
Ranitidinetablet, film coated300 mg/1oralGlenmark Generics Inc., USA2008-11-192016-04-05Us
Ranitidinesolution15 mg/mLoralHi Tech Pharmacal Co., Inc.2011-03-222016-04-05Us
Ranitidinetablet300 mg/1oralPhysicians Total Care, Inc.2003-09-192016-04-05Us
Ranitidinetablet, film coated300 mg/1oralIVAX Pharmaceuticals, Inc.1998-04-012016-04-23Us
Ranitidinetablet150 mg/1oralWockhardt Limited1998-12-172016-04-05Us
Ranitidinetablet150 mg/1oralAidarex Pharmaceuticals LLC2009-12-162016-04-05Us
Ranitidinetablet, film coated150 mg/1oralCardinal Health2008-11-192016-04-05Us
Ranitidinetablet150 mg/1oralSTAT Rx USA LLC2009-12-162016-04-05Us
Ranitidinetablet, film coated300 mg/1oralAmerican Health Packaging2015-03-312016-04-05Us
Ranitidinesolution15 mg/mLoralAmneal Pharmaceuticals of New York, LLC2010-03-122016-04-05Us
Ranitidinetablet, film coated150 mg/1oralGlenmark Generics Inc., USA2008-11-192016-04-05Us
Ranitidinetablet300 mg/1oralWockhardt Limited2009-12-112016-04-05Us
Ranitidinesyrup15 mg/mLoralHeritage Pharmaceuticals Inc.2013-07-152016-04-05Us
Ranitidinetablet150 mg/1oralCardinal Health2010-01-142016-04-05Us
Ranitidinetablet150 mg/1oralBlenheim Pharmacal, Inc.2010-10-212016-04-05Us
Ranitidinetablet150 mg/1oralbryant ranch prepack2009-12-162016-04-05Us
Ranitidinetablet300 mg/1oralSt Marys Medical Park Pharmacy2014-01-302016-04-05Us
Ranitidinetablet150 mg/1oralAmerican Health Packaging2014-07-072016-04-05Us
Ranitidinetablet300 mg/1oralWOCKHARDT USA LLC1998-12-172016-04-05Us
Ranitidinetablet300 mg/1oralAv Pak2015-08-042016-04-05Us
Ranitidinetablet150 mg/1oralMedsource Pharmaceuticals2009-12-162016-04-05Us
Ranitidinetablet150 mg/1oralPhysicians Total Care, Inc.1999-09-212016-04-05Us
Ranitidinetablet, film coated150 mg/1oralREMEDYREPACK INC.2013-07-082016-04-05Us
Ranitidinetablet, film coated150 mg/1oralIVAX Pharmaceuticals, Inc.1997-09-122016-04-23Us
Ranitidinetablet150 mg/1oralContract Pharmacy Services Pa2010-06-302016-04-05Us
Ranitidinetablet150 mg/1oralWOCKHARDT USA LLC1998-12-172016-04-05Us
Ranitidinetablet150 mg/1oralAv Pak2015-08-042016-04-05Us
Ranitidinetablet300 mg/1oralPd Rx Pharmaceuticals, Inc.2009-12-162016-04-05Us
Ranitidinetablet, film coated300 mg/1oralNcs Health Care Of Ky, Inc Dba Vangard Labs2009-11-062016-04-23Us
Ranitidinetablet, film coated150 mg/1oralREMEDYREPACK INC.2013-05-092016-04-05Us
Ranitidinesolution15 mg/mLoralPharmaceutical Associates, Inc.2009-09-192016-04-23Us
Ranitidinesyrup15 mg/mLoralWockhardt Limited2009-05-262016-04-05Us
Ranitidinetablet150 mg/1oralCardinal Health2010-07-232016-04-05Us
Ranitidinetablet, film coated150 mg/1oralBlenheim Pharmacal, Inc.2014-02-252016-04-05Us
Ranitidinetablet, film coated300 mg/1oralProficient Rx LP2008-11-192016-04-05Us
Ranitidinetablet, film coated300 mg/1oralApotex Corp1997-09-132016-04-05Us
Ranitidine 75tablet75 mg/1oralREMEDYREPACK INC.2013-09-262016-04-05Us
Ranitidine Hydrochlorideinjection25 mg/mLintramuscular; intravenousZydus Pharmaceuticals (USA) Inc.2013-03-012016-04-05Us
Ranitidine Hydrochloridecapsule150 mg/1oralRebel Distributors Corp1997-10-222016-04-05Us
Ranitidine Hydrochloridetablet, film coated150 mg/1oralMylan Institutional Inc.1997-07-112016-04-05Us
Ranitidine Hydrochloridetablet300 mg/1oralREMEDYREPACK INC.2011-10-032016-04-05Us
Ranitidine Hydrochloridecapsule150 mg/1oralNcs Health Care Of Ky, Inc Dba Vangard Labs1997-10-222016-04-23Us
Ranitidine Hydrochloridetablet150 mg/1oralREMEDYREPACK INC.2011-08-112016-04-05Us
Ranitidine Hydrochloridecapsule300 mg/1oralDr. Reddy's Laboratories Limited2001-04-012016-04-05Us
Ranitidine Hydrochloridetablet150 mg/1oralDIRECT RX2014-01-012016-04-05Us
Ranitidine Hydrochloridesolution15 mg/mLoralPrecision Dose Inc.2011-04-252016-03-11Us
Ranitidine Hydrochloridetablet150 mg/1oralREMEDYREPACK INC.2011-04-142016-04-05Us
Ranitidine Hydrochloridecapsule150 mg/1oralDr. Reddy's Laboratories Limited2001-01-122016-04-05Us
Ranitidine Hydrochloridecapsule300 mg/1oralSandoz Inc1997-10-222016-04-05Us
Ranitidine Hydrochloridesolution75 mg/5mLoralPrecision Dose Inc.2006-10-132016-03-11Us
Ranitidine Hydrochlorideinjection25 mg/mLintramuscular; intravenousCadila Healthcare Limited2013-03-012016-04-05Us
Ranitidine Hydrochloridecapsule150 mg/1oralSandoz Inc1997-10-222016-04-05Us
Ranitidine Hydrochloridetablet, film coated150 mg/1oralCardinal Health2011-05-202016-04-05Us
Ranitidine Hydrochloridesolution150 mg/10mLoralPrecision Dose Inc.2003-08-212016-04-05Us
Ranitidine Hydrochlorideinjection25 mg/mLintramuscular; intravenousCadila Healthcare Limited2013-03-012016-04-05Us
Ranitidine Hydrochloridetablet300 mg/1oralREMEDYREPACK INC.2010-10-252016-04-05Us
Ranitidine Hydrochloridetablet, film coated300 mg/1oralSandoz Inc1997-08-292016-04-05Us
Ranitidine Hydrochloridetablet, film coated300 mg/1oralbryant ranch prepack1997-08-292016-04-05Us
Ranitidine Hydrochloridetablet, film coated150 mg/1oralREMEDYREPACK INC.2014-10-132016-04-05Us
Ranitidine Hydrochloridetablet, film coated150 mg/1oralKeltman Pharmaceuticals Inc.2009-07-012016-04-05Us
Ranitidine Hydrochloridetablet, film coated150 mg/1oralSandoz Inc1997-08-292016-04-05Us
Ranitidine Hydrochlorideinjection25 mg/mLintramuscular; intravenousZydus Pharmaceuticals (USA) Inc.2013-03-012016-04-05Us
Ranitidine Hydrochloridetablet, film coated150 mg/1oralState of Florida DOH Central Pharmacy2009-07-012016-04-05Us
Ranitidine Hydrochloridecapsule300 mg/1oralRebel Distributors Corp1997-10-222016-04-05Us
Over the Counter Products
NameDosageStrengthRouteLabellerMarketing StartMarketing End
7 Select Acid Reducertablet, film coated150 mg/1oral7 Eleven2014-04-222016-04-05Us
Acid Reducertablet150 mg/1oralPreferred Plus (Kinray)2014-01-272016-04-05Us
Acid Reducertablet150 mg/1oralP and L Development of New York Corporation2013-03-252016-04-05Us
Acid Reducertablet150 mg/1oralWin Co Foods, Llc2012-08-152016-04-05Us
Acid Reducertablet150 mg/1oralChain Drug Marketing Association Inc.2012-03-302016-04-05Us
Acid Reducertablet75 mgoralVita Health Products Inc2008-01-31Not applicableCanada
Acid Reducertablet, film coated75 mg/1oralPreferred Plus (Kinray)2014-01-272016-04-05Us
Acid Reducertablet, film coated75 mg/1oralWin Co Foods, Llc2012-08-022016-04-05Us
Acid Reducertablet150 mg/1oralSelect Brand2012-03-302016-04-05Us
Acid Reducertablet75 mg/1oralShopko Stores Operating Co., LLC2013-06-102016-04-05Us
Acid Reducertablet75 mg/1oralMeijer Distribution Inc1998-09-292016-04-05Us
Acid Reducertablet, film coated75 mg/1oralRite Aid2013-06-152018-07-15Us
Acid Reducertablet150 mg/1oralH E B2014-04-112016-04-05Us
Acid Reducertablet75 mg/1oralHy Vee Inc2009-11-232016-04-05Us
Acid Reducertablet, film coated150 mg/1oralMeijer Distribution Inc2013-08-232016-04-05Us
Acid Reducertablet150 mg/1oralWestern Family Foods Inc2008-03-142016-04-05Us
Acid Reducertablet150 mg/1oralMc Kesson2014-01-072016-04-05Us
Acid Reducertablet150 mgoralApotex Inc2014-03-20Not applicableCanada
Acid Reducertablet, film coated150 mg/1oralNash Finch Company2013-06-152018-07-15Us
Acid Reducertablet150 mgoralPharmascience IncNot applicableNot applicableCanada
Acid Reducertablet150 mg/1oralMc Kesson2014-01-072016-04-05Us
Acid Reducertablet150 mg/1oralShopko Stores Operating Co., LLC2013-06-052016-04-05Us
Acid Reducertablet, film coated150 mg/1oralRite Aid Corporation2011-10-262016-04-05Us
Acid Reducertablet, film coated75 mg/1oralGood Sense2013-10-112016-04-05Us
Acid Reducertablet75 mg/1oralRite Aid Corporation2011-11-042016-04-05Us
Acid Reducertablet, film coated150 mg/1oralCVS Pharmacy2011-09-212016-04-05Us
Acid Reducertablet75 mg/1oralSafeway2009-05-292016-04-05Us
Acid Reducertablet150 mg/1oralRite Aid Corporation2008-12-032016-04-05Us
Acid Reducertablet, film coated150 mg/1oralCVS Pharmacy2015-09-142016-04-05Us
Acid Reducertablet75 mgoralPharmascience Inc2004-07-13Not applicableCanada
Acid Reducertablet150 mg/1oralSafeway2008-02-202016-04-05Us
Acid Reducertablet, film coated150 mg/1oralShopko Stores Operating Co., LLC2013-06-052016-04-05Us
Acid Reducertablet150 mg/1oralMajor Pharmaceuticals2013-10-012016-04-05Us
Acid Reducertablet75 mg/1oralMedicine Shoppe International Inc2009-06-112016-04-05Us
Acid Reducertablet150 mg/1oralCardinal Health2013-09-252016-04-05Us
Acid Reducertablet150 mg/1oralFred's Inc.2012-03-302016-04-05Us
Acid Reducertablet75 mg/1oralPublix Super Markets Inc2009-06-082016-04-05Us
Acid Reducertablet75 mgoralWestcan Pharmaceuticals Ltd.Not applicableNot applicableCanada
Acid Reducertablet, film coated150 mg/1oralH E B2015-11-252016-04-05Us
Acid Reducertablet75 mg/1oralHannaford Brothers Company2009-08-112016-04-05Us
Acid Reducertablet, film coated75 mg/1oralOhm Laboratories Inc.2012-07-102016-04-05Us
Acid Reducertablet150 mg/1oralCVS Pharmacy2012-08-212016-04-05Us
Acid Reducertablet150 mg/1oralValu Merchandisers Company2012-03-302016-04-05Us
Acid Reducertablet75 mgoralMylan Pharmaceuticals Ulc1998-06-25Not applicableCanada
Acid Reducertablet75 mgoralLaboratoire Riva IncNot applicableNot applicableCanada
Acid Reducertablet75 mgoralVita Health Products Inc2006-03-312009-08-06Canada
Acid Reducertablet, film coated75 mg/1oralSafeway Inc.2013-12-132016-04-05Us
Acid Reducertablet, film coated150 mg/1oralShopko Stores Operating Co., LLC2013-06-052016-04-05Us
Acid Reducertablet150 mg/1oralWal Mart Stores, Inc2013-09-092016-04-05Us
Acid Reducertablet150 mg/1oralOhm Laboratories Inc.2011-06-282016-04-05Us
Acid Reducertablet75 mgoralApotex Inc1999-02-08Not applicableCanada
Acid Reducertablet150 mg/1oralPremier Value2012-03-302016-04-05Us
Acid Reducertablet75 mgoralNovopharm LimitedNot applicableNot applicableCanada
Acid Reducertablet75.0 mgoralStanley Pharmaceuticals, A Division Of Vita Health Products Inc.2000-03-272004-07-26Canada
Acid Reducertablet, film coated150 mg/1oralH E B2015-11-302016-04-05Us
Acid Reducertablet, film coated150 mg/1oralMeijer Distribution Inc2011-09-212016-04-05Us
Acid Reducer 150tablet, film coated150 mg/1oralSafeway2011-09-292016-04-05Us
Acid Reducer 150tablet, coated150 mg/1oralSAFEWAY INC2012-05-142016-04-05Us
Acid Reducer 150tablet, film coated150 mg/1oralHy Vee Inc2012-09-172016-04-05Us
Acid Reducer Maximum Strengthtablet150 mg/1oralL. Perrigo Company2008-02-192016-04-23Us
Acid Reducer Maximum Strengthtablet150 mg/1oralHy Vee Inc2008-02-172016-04-05Us
Acid Reducer Maximum Strengthtablet150 mg/1oralMeijer Distribution Inc2008-02-132016-04-05Us
Acid Reducer Maximum Strengthtablet, film coated150 mg/1oralFamily Dollar2013-06-152018-07-15Us
Acid Reducer Maximum Strength Non-prescriptiontablet150 mgoralMylan Pharmaceuticals UlcNot applicableNot applicableCanada
Acid Reducer Regular Strengthtablet, film coated75 mg/1oralKmart Corporation2013-06-152018-07-15Us
Acid Relieftablet75 mg/1oralWestern Family Foods Inc2009-05-282016-04-05Us
Acid Relieftablet, film coated150 mg/1oralWestern Family Foods Inc2011-10-032016-04-05Us
Acid Relieftablet, film coated150 mg/1oralWestern Family Foods Inc2013-11-272016-04-05Us
Aptidine 75tablet75 mg/1oralA P J Laboratories Limited2013-03-012016-04-05Us
Being Well Heartburn Relieftablet, film coated150 mg/1oralSave A Lot Food Stores Ltd2013-09-092016-04-05Us
Being Well Heartburn Relief Acid Reducertablet150 mg/1oralSave A Lot Food Stores Ltd2010-03-232016-04-05Us
Berkley and Jensen Acid Reducertablet, film coated150 mg/1oralBJWC2012-02-032016-04-05Us
Berkley and Jensen Acid Reducer Maximum Strengthtablet150 mg/1oralBJWC2009-09-232016-04-05Us
Berkley and Jensen Ranitidinetablet, film coated150 mg/1oralBJWC2014-07-012016-04-05Us
Care One Acid Reducertablet150 mg/1oralAmerican Sales Company2008-02-132016-04-05Us
Careone Acid Reducertablet, film coated150 mg/1oralAmerican Sales Company2013-09-222016-04-05Us
Careone Acid Reducertablet, film coated150 mg/1oralAmerican Sales Company2013-11-302016-04-05Us
Careone Acid Reducertablet75 mg/1oralAmerican Sales Company2009-05-292016-04-05Us
Cool Mint Acid Reducertablet, film coated150 mg/1oralRite Aid Corporation2011-12-072016-04-05Us
Dg Health Acid Reducertablet, film coated150 mg/1oralDolgencorp, LLC2013-08-292016-04-05Us
Dg Health Acid Reducertablet75 mg/1oralDolgencorp Inc2010-03-272016-04-05Us
Dg Health Acid Reducer Maximum Strengthtablet150 mg/1oralDolgencorp Inc2010-02-062016-04-05Us
Dg Health Heartburn Relieftablet, film coated150 mg/1oralDolgencorp, LLC2015-11-232016-04-05Us
Equalinetablet150 mg/1oralSUPERVALU INC.2011-06-282016-04-05Us
Equaline Heartburn Relieftablet75 mg/1oralSupervalu Inc2009-05-112016-04-05Us
Equaline Heartburn Relieftablet, film coated150 mg/1oralSupervalu Inc2012-07-252016-04-05Us
Equate Acid Reducertablet, film coated150 mg/1oralWal Mart Stores Inc2012-02-122016-04-05Us
Equate Ranitidinetablet, film coated150 mg/1oralWal Mart Stores Inc2012-02-122016-04-05Us
Equate Ranitidine Acid Reducertablet, film coated150 mg/1oralWal Mart Stores Inc2015-02-152016-04-05Us
Equate Ranitidine Acid Reducertablet, film coated150 mg/1oralWal Mart Stores Inc2013-02-222016-04-05Us
Exchange Select Acid Reducertablet, film coated150 mg/1oralArmy & Air Force Exchange Service2014-01-062016-04-05Us
Exchange Select Acid Reducertablet75 mg/1oralArmy & Air Force Exchange Service2012-09-122016-04-05Us
Family Wellness Acid Reducertablet75 mg/1oralFamily Dollar Services Inc2012-08-022016-04-05Us
Formu Care Ranitidinetablet150 mg/1oralAccess Business Group LLC2010-09-242016-04-05Us
Formucare Ranitidinetablet75 mg/1oralAccess Business Group International LLC2009-09-092016-04-05Us
Good Neighbor Pharmacy Acid Controltablet75 mg/1oralAmerisource Bergen2009-05-162016-04-05Us
Good Neighbor Pharmacy Acid Control 150tablet, film coated150 mg/1oralAmerisource Bergen2012-02-082016-04-05Us
Good Neighbor Pharmacy Acid Control 150tablet, film coated150 mg/1oralAmerisource Bergen2011-10-042016-04-05Us
Good Neighbor Pharmacy Acid Control 150 Maximum Strengthtablet150 mg/1oralAmerisource Bergen2008-02-192016-04-05Us
Good Sense Acid Reducertablet, film coated150 mg/1oralL Perrigo Company2011-10-212016-04-23Us
Good Sense Acid Reducertablet, film coated150 mg/1oralL. Perrigo Company2014-02-052016-04-23Us
Good Sense Acid Reducertablet75 mg/1oralL Perrigo Company2009-05-212016-04-23Us
Health Mart Acid Reducertablet, film coated150 mg/1oralMcKesson2012-03-202016-04-05Us
Health Mart Acid Reducertablet150 mg/1oralMc Kesson2012-03-202016-04-05Us
Health Mart Acid Reducertablet75 mg/1oralMc Kesson2012-03-202016-04-05Us
Healthy Accents Ranitidinetablet, film coated150 mg/1oralDZA Brands LLC2013-10-092016-04-05Us
Healthy Accents Ranitidinetablet150 mg/1oralDZA Brands LLC2008-11-122016-04-05Us
Heartburn Relieftablet, film coated150 mg/1oralKroger Company2011-09-202016-04-05Us
Heartburn Relieftablet, film coated150 mg/1oralKroger Company2013-08-312016-04-05Us
Heartburn Relieftablet, film coated150 mg/1oralH E B2011-11-252016-04-05Us
Heartburn Relieftablet, film coated150 mg/1oralH E B2013-07-232016-04-05Us
Heartburn Relieftablet150 mg/1oralKroger Company2008-02-252016-04-05Us
Heartburn Relieftablet75 mg/1oralSUPERVALU INC.2013-06-152018-07-15Us
Heartburn Relief 150tablet, film coated150 mg/1oralKroger Company2015-05-122016-04-05Us
Heartburn Relief 150tablet, film coated150 mg/1oralKroger Company2013-08-312016-04-05Us
Heartburn Relief 150 Maximum Strengthtablet, film coated150 mg/1oralSalado Sales, Inc.2013-06-152018-07-15Us
Heartburn Relief Acid Reducertablet75 mg/1oralKroger Company2009-05-222016-04-05Us
Heartburn Relief Maximum Strengthtablet, film coated150 mg/1oralSUPERVALU INC.2013-06-152018-07-15Us
Heartburn Relief Maximum Strengthtablet, film coated150 mg/1oralGreenbrier International, Inc.2013-06-152016-04-05Us
Heratburn Relieftablet, coated150 mg/1oralThe Kroger Co.2011-04-242016-04-05Us
Kirkland Signature Acid Reducertablet, film coated150 mg/1oralCostco Wholesale Company2013-04-242016-04-05Us
Leader Acid Controltablet, film coated150 mg/1oralCardinal Health2011-11-112016-04-05Us
Leader Acid Controltablet, film coated150 mg/1oralCardinal Health2011-11-112016-04-05Us
Leader Acid Controltablet, film coated150 mg/1oralCardinal Health2014-03-112016-04-05Us
Leader Acid Controltablet, film coated150 mg/1oralCardinal Health2011-05-252016-04-05Us
Leader Acid Controltablet, film coated150 mg/1oralREMEDYREPACK INC.2015-03-272016-04-05Us
Leader Acid Control Acid Reducertablet75 mg/1oralCardinal Health2009-05-212016-04-05Us
Leader Acid Control Maximum Strengthtablet150 mg/1oralCardinal Health2008-02-202016-04-05Us
Major Ranitidine Maximum Strengthtablet150 mg/1oralMajor Pharmaceuticals2008-02-182016-04-05Us
Maximum Strengthtablet150 mg/1oralPublix Super Markets Inc2009-01-272016-04-05Us
Maximum Strength Acid Reducertablet150 mgoralVita Health Products Inc2007-10-12Not applicableCanada
Maximum Strength Acid Reducertablet150 mg/1oralL.N.K. International, Inc.2013-06-152018-07-15Us
Maximum Strength Acid Reducer Without Prescriptiontablet150 mgoralPharmel IncNot applicableNot applicableCanada
Maximum Strength Acid Reducer Without Prescriptiontablet150 mgoralPharmascience Inc2007-07-18Not applicableCanada
Maximum Strength Ranitidinetablet, film coated150 mg/1oralPublix Super Markets Inc2013-11-252016-04-05Us
Maximum Strength Zantactablet, coated150 mg/1oralBoehringer Ingelheim Pharmaceuticals Inc.2006-12-212016-04-23Us
Ranitidinetablet, film coated75 mg/1oralWalgreen Company2013-09-242016-04-23Us
Ranitidinetablet, film coated75 mg/1oralSUPERVALU INC.2012-07-102016-04-05Us
Ranitidinetablet, film coated75 mg/1oralSunmark2013-09-202016-04-05Us
Ranitidinetablet150 mg/1oralShopko Stores Operating Co., LLC.2010-07-112016-04-05Us
Ranitidinetablet, film coated75 mg/1oralApotex Corp.2005-01-242016-04-05Us
Ranitidinetablet75 mg/1oralShasun Pharmaceuticals Limited2012-02-292016-04-05Us
Ranitidinetablet, film coated150 mg/1oralApotex Corp.2013-07-152016-04-05Us
Ranitidinetablet150 mg/1oralShasun Pharmaceuticals Limited2011-06-282016-04-05Us
Ranitidinetablet, coated150 mg/1oralWockhardt USA LLC.2007-11-262016-04-05Us
Ranitidinetablet, film coated75 mg/1oralHealth Mart2013-09-202016-04-05Us
Ranitidinetablet, film coated150 mg/1oralLiberty Pharmaceuticals, Inc.2013-07-152016-04-23Us
Ranitidinetablet, film coated75 mg/1oralAmerisource Bergen2013-09-062016-04-05Us
Ranitidinetablet, coated150 mg/1oralDr. Reddy's Laboratories Limited2009-12-022016-04-05Us
Ranitidinetablet, coated150 mg/1oralWockhardt Limited2007-11-262016-04-05Us
Ranitidinetablet, coated75 mg/1oralWockhardt USA LLC.2008-07-312016-04-05Us
Ranitidinetablet75 mg/1oralDr. Reddy's Laboratories Limited2000-03-012016-04-05Us
Ranitidinetablet, coated75 mg/1oralWockhardt Limited2008-07-312016-04-05Us
Ranitidinetablet, film coated75 mg/1oralFred's Inc.2013-09-012016-04-05Us
Ranitidinetablet75 mgoralPharmascience IncNot applicableNot applicableCanada
Ranitidinetablet150 mg/1oralMedline Industries, Inc.2012-03-302016-04-05Us
Ranitidinetablet, film coated75 mg/1oralCVS Pharmacy, Inc2013-09-192016-04-05Us
Ranitidinetablet, film coated75 mg/1oralValu Merchandisers Company2012-07-102016-04-05Us
Ranitidinetablet, film coated75 mg/1oralMajor Pharmaceuticals2013-10-012016-04-05Us
Ranitidinetablet, film coated75 mg/1oralWal Mart Stores, Inc2012-07-102016-04-05Us
Ranitidinetablet, film coated75 mg/1oralCardinal Health2013-09-252016-04-05Us
Ranitidinetablet, film coated75 mg/1oralREMEDYREPACK INC.2015-11-122016-04-05Us
Ranitidinetablet75 mg/1oralP and L Development of New York Corporation2013-03-192016-04-05Us
Ranitidinetablet, film coated75 mg/1oralChain Drug Marketing Association Inc.2012-07-102016-04-05Us
Ranitidinetablet150 mg/1oralShopko Stores Operating Co., LLC2012-03-302016-04-05Us
Ranitidine - Acid Reducertablet, film coated75 mg/1oralChain Drug Consortium, Llc.2012-07-102016-04-05Us
Ranitidine 150tablet, coated150 mg/1oralWalmart Stores Inc.2010-01-052016-04-05Us
Ranitidine 75tablet75 mg/1oralMajor Pharmaceuticals2009-05-262016-04-05Us
Ranitidine 75tablet75 mg/1oralMeijer Distribution Inc2014-09-222016-04-05Us
Ranitidine 75tablet75 mg/1oralThe Kroger Co.2011-03-312016-04-05Us
Ranitidine 75tablet75 mg/1oralTarget Brands Inc2013-11-222016-04-05Us
Ranitidine Acid Reducertablet, film coated150 mg/1oralHy Vee Inc2013-12-022016-04-05Us
Ranitidine Hydrochloridetablet, film coated75 mg/1oralSelect Brand2012-07-102016-04-05Us
Ranitidine Non Prescriptiontablet150 mgoralSandoz Canada IncorporatedNot applicableNot applicableCanada
Regular Strength Acid Reducertablet150 mg/1oralFamily Dollar2011-06-282016-04-05Us
Regular Strength Acid Reducertablet75 mg/1oralL.N.K. International, Inc.2013-06-152018-07-15Us
Regular Strength Acid Reducertablet75 mg/1oralFamily Dollar2013-06-152018-07-15Us
Regular Strength Acid Reducertablet75 mg/1oralFamily Dollar2013-09-242016-04-05Us
Rexall Heartburn Relieftablet, film coated150 mg/1oralDolgencorp, LLC2011-10-032016-04-05Us
Riva-ranitidine 75mgtablet75 mgoralLaboratoire Riva Inc1999-07-27Not applicableCanada
Rx Act Heartburn Relieftablet150 mg/1oralH E B2008-02-202016-04-05Us
Shoprite Acid Reducertablet, film coated150 mg/1oralWakefern Food Corporation2013-06-202016-04-05Us
Shoprite Acid Reducertablet150 mg/1oralWakefern Food Corporation2013-06-162016-04-05Us
Shoprite Acid Reducer Maximum Strengthtablet, film coated150 mg/1oralWakefern Food Corporation2013-06-162016-04-05Us
Signature Care Acid Controltablet, film coated150 mg/1oralSafeway2015-09-012016-04-05Us
Smart Sense Acid Reducertablet75 mg/1oralKmart Corporation2010-12-152016-04-05Us
Smart Sense Acid Reducertablet150 mg/1oralKmart Corporation2010-11-242016-04-05Us
Smart Sense Acid Reducertablet, film coated150 mg/1oralKmart Corporation2011-11-222016-04-05Us
Smart Sense Ranitidinetablet, film coated150 mg/1oralKmart Corporation2011-05-272016-04-05Us
Smart Sense Ranitidinetablet, film coated150 mg/1oralKmart Corporation2014-03-212016-04-05Us
Smart Sense Ranitidinetablet150 mg/1oralKmart Corporation2010-11-242016-04-05Us
Sunmark Acid Reducertablet75 mg/1oralMc Kesson2009-07-102016-04-05Us
Sunmark Acid Reducer Maximum Strengthtablet150 mg/1oralMc Kesson2008-02-132016-04-05Us
Topcare Heartburn Relieftablet75 mg/1oralTopco Associates LLC2009-06-112016-04-05Us
Topcare Heartburn Relief 150tablet, film coated150 mg/1oralTopco Associates LLC2011-10-102016-04-05Us
Topcare Heartburn Relief 150tablet, film coated150 mg/1oralTopco Associates LLC2013-10-082016-04-05Us
Topcare Heartburn Relief 150tablet150 mg/1oralTopco Associates LLC2008-02-132016-04-05Us
Up and Up Acid Reducer Non Prescription Strengthtablet75 mg/1oralTarget Corporation2009-07-312016-04-05Us
Up and Up Ranitidinetablet150 mg/1oralTarget Corporation2012-05-032016-04-05Us
Up and Up Ranitidinetablet, film coated150 mg/1oralTarget Corporation2015-04-012016-04-05Us
Up and Up Ranitidinetablet, film coated150 mg/1oralTarget Corporation2013-09-112016-04-05Us
Wal Zan 150tablet, film coated150 mg/1oralWalgreen Company2011-09-172016-04-23Us
Wal Zan 75tablet75 mg/1oralWalgreen Company2009-02-242016-04-23Us
Wal Zan Acid Reducer Maximum Strengthtablet150 mg/1oralWalgreen Company2008-02-042016-04-23Us
Wal-zantablet150 mg/1oralWalgreens Company2015-07-312016-04-23Us
Wal-zantablet, coated150 mg/1oralWalgreens Company2011-06-112016-04-23Us
Wal-zantablet75 mg/1oralWalgreens Company2015-07-312016-04-23Us
Wal-zantablet150 mg/1oralWalgreen Company2011-06-282016-04-23Us
Wal-zan 75tablet75 mg/1oralWalgreens Company2014-01-062016-04-23Us
Zantac - Tab 75mgtablet75 mgoralMcneil Consumer Healthcare Division Of Johnson & Johnson Inc1997-09-26Not applicableCanada
Zantac 150tablet150 mg/1oralBoehringer Ingelheim Promeco s.a. De c.v.2016-04-152016-04-23Us
Zantac 150 Acid Reducertablet150 mg/1oralLil' Drug Store Products, Inc2010-11-012016-04-05Us
Zantac 75tablet, coated75 mg/1oralBoehringer Ingelheim Pharmaceuticals Inc.2006-12-212016-04-23Us
Zantac 75tablet75 mg/1oralBoehringer Ingelheim Promeco s.a. De c.v.2016-04-152016-04-23Us
Zantac 75tablet, coated75 mg/1oralCarilion Materials Management2006-12-212016-04-05Us
Zantac Maximum Strength 150 Cool Minttablet, coated150 mg/1oralBoehringer Ingelheim Pharmaceuticals Inc.2006-12-212016-04-23Us
Zantac Maximum Strength Non-prescriptiontablet150 mgoralMcneil Consumer Healthcare Division Of Johnson & Johnson Inc2007-03-09Not applicableCanada
International Brands
NameCompany
AlquenNot Available
CoralenNot Available
GastrolavNot Available
GastrosedolNot Available
KuracidNot Available
Nu-RanitNot Available
Pep-RaniNot Available
PtinolinNot Available
RaniberlNot Available
RaniblocNot Available
RanicuxNot Available
RanidilNot Available
RanidinNot Available
RanidineNot Available
RaniduraNot Available
RanifurNot Available
RanigastNot Available
RaniplexNot Available
RanisanNot Available
RanitabNot Available
RaniticNot Available
RanitidinNot Available
RanitinNot Available
RanitineNot Available
RanobelNot Available
RantacidNot Available
RanuberNot Available
RenatacNot Available
SostrilNot Available
TanidinaNot Available
ToriolNot Available
UlcodinNot Available
ZandidNot Available
ZanticNot Available
Brand mixtures
NameLabellerIngredients
GabitidinePhysician Therapeutics Llc
SentradinePhysician Therapeutics Llc
Salts
Name/CASStructureProperties
Ranitidine bismuth citrate
ThumbNot applicableDBSALT001128
Ranitidine Hydrochloride
66357-59-3
Thumb
  • InChI Key: GGWBHVILAJZWKJ-KJEVSKRMSA-N
  • Monoisotopic Mass: 350.117939019
  • Average Mass: 350.865
DBSALT000487
Categories
UNII884KT10YB7
CAS number66357-35-5
WeightAverage: 314.404
Monoisotopic: 314.14126128
Chemical FormulaC13H22N4O3S
InChI KeyInChIKey=VMXUWOKSQNHOCA-UKTHLTGXSA-N
InChI
InChI=1S/C13H22N4O3S/c1-14-13(9-17(18)19)15-6-7-21-10-12-5-4-11(20-12)8-16(2)3/h4-5,9,14-15H,6-8,10H2,1-3H3/b13-9+
IUPAC Name
dimethyl[(5-{[(2-{[(E)-1-(methylamino)-2-nitroethenyl]amino}ethyl)sulfanyl]methyl}furan-2-yl)methyl]amine
SMILES
CN\C(NCCSCC1=CC=C(CN(C)C)O1)=C/[N+]([O-])=O
Taxonomy
DescriptionThis compound belongs to the class of organic compounds known as aralkylamines. These are alkylamines in which the alkyl group is substituted at one carbon atom by an aromatic hydrocarbyl group.
KingdomOrganic compounds
Super ClassOrganonitrogen compounds
ClassAmines
Sub ClassAralkylamines
Direct ParentAralkylamines
Alternative Parents
Substituents
  • Aralkylamine
  • Heteroaromatic compound
  • Furan
  • Organic nitro compound
  • Tertiary aliphatic amine
  • Tertiary amine
  • Organic nitrite
  • C-nitro compound
  • Oxacycle
  • Organoheterocyclic compound
  • Dialkylthioether
  • Organic 1,3-dipolar compound
  • Propargyl-type 1,3-dipolar organic compound
  • Allyl-type 1,3-dipolar organic compound
  • Sulfenyl compound
  • Thioether
  • Organic oxoazanium
  • Hydrocarbon derivative
  • Organic salt
  • Organosulfur compound
  • Organooxygen compound
  • Organic zwitterion
  • Aromatic heteromonocyclic compound
Molecular FrameworkAromatic heteromonocyclic compounds
External Descriptors
Pharmacology
IndicationUsed in the treatment of peptic ulcer disease (PUD), dyspepsia, stress ulcer prophylaxis, and gastroesophageal reflux disease (GERD).
PharmacodynamicsRanitidine is a histamine H2-receptor antagonist similar to cimetidine and famotidine. An H2-receptor antagonist, often shortened to H2 antagonist, is a drug used to block the action of histamine on parietal cells in the stomach, decreasing acid production by these cells. These drugs are used in the treatment of dyspepsia, however their use has waned since the advent of the more effective proton pump inhibitors. Like the H1-antihistamines, the H2 antagonists are inverse agonists rather than true receptor antagonists.
Mechanism of actionThe H2 antagonists are competitive inhibitors of histamine at the parietal cell H2 receptor. They suppress the normal secretion of acid by parietal cells and the meal-stimulated secretion of acid. They accomplish this by two mechanisms: histamine released by ECL cells in the stomach is blocked from binding on parietal cell H2 receptors which stimulate acid secretion, and other substances that promote acid secretion (such as gastrin and acetylcholine) have a reduced effect on parietal cells when the H2 receptors are blocked.
Related Articles
AbsorptionApproximately 50% bioavailability orally.
Volume of distribution
  • 1.4 L/kg
  • 1.76 L/kg [clinically significant renal function impairment (creatinine clearance 25 to 35 mL/min)]
Protein binding15%
Metabolism

Hepatic. Ranitidine is metabolized to the N-oxide, S-oxide, and N-desmethyl metabolites, accounting for approximately 4%, 1%, and 1% of the dose, respectively.

Route of eliminationThe principal route of excretion is the urine (active tubular excretion, renal clearance 410mL/min), with approximately 30% of the orally administered dose collected in the urine as unchanged drug in 24 hours.
Half life2.8-3.1 hours
Clearance
  • 29 mL/min [clinically significant renal function impairment]
  • 3 mL/min/Kg [neonatal patients]
ToxicityLD50=77mg/kg (orally in mice). Symptoms of overdose include muscular tremors, vomiting, and rapid respiration.
Affected organisms
  • Humans and other mammals
Pathways
PathwayCategorySMPDB ID
Ranitidine Action PathwayDrug actionSMP00230
SNP Mediated EffectsNot Available
SNP Mediated Adverse Drug ReactionsNot Available
ADMET
Predicted ADMET features
PropertyValueProbability
Human Intestinal Absorption+0.9936
Blood Brain Barrier-0.8783
Caco-2 permeable-0.5838
P-glycoprotein substrateSubstrate0.8527
P-glycoprotein inhibitor INon-inhibitor0.8782
P-glycoprotein inhibitor IINon-inhibitor0.8893
Renal organic cation transporterNon-inhibitor0.8177
CYP450 2C9 substrateNon-substrate0.7702
CYP450 2D6 substrateSubstrate0.7414
CYP450 3A4 substrateNon-substrate0.5565
CYP450 1A2 substrateNon-inhibitor0.9046
CYP450 2C9 inhibitorNon-inhibitor0.9071
CYP450 2D6 inhibitorNon-inhibitor0.923
CYP450 2C19 inhibitorNon-inhibitor0.9025
CYP450 3A4 inhibitorNon-inhibitor0.8308
CYP450 inhibitory promiscuityLow CYP Inhibitory Promiscuity0.7819
Ames testNon AMES toxic0.9132
CarcinogenicityNon-carcinogens0.8077
BiodegradationNot ready biodegradable0.9249
Rat acute toxicity2.0903 LD50, mol/kg Not applicable
hERG inhibition (predictor I)Strong inhibitor0.8628
hERG inhibition (predictor II)Non-inhibitor0.8734
ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397 )
Pharmacoeconomics
Manufacturers
  • Dr reddys laboratories ltd
  • Genpharm inc
  • Sandoz inc
  • Teva pharmaceuticals usa inc
  • Glaxosmithkline
  • Bedford laboratories div ben venue laboratories inc
  • Ben venue laboratories inc
  • Alpharma us pharmaceuticals division
  • Amneal pharmaceuticals
  • Apotex inc
  • Aurobindo pharma usa inc
  • Cypress pharmaceutical inc
  • Pharmaceutical assoc inc div beach products
  • Ranbaxy laboratories ltd
  • Vintage pharmaceuticals inc
  • Wockhardt ltd
  • Boehringer ingelheim pharmaceuticals inc
  • Amneal pharmaceuticals ny llc
  • Boehringer ingelheim corp
  • Contract pharmacal corp
  • Dr reddys laboratories inc
  • Glenmark generics inc usa
  • Ivax pharmaceuticals inc sub teva pharmaceuticals usa
  • Mylan pharmaceuticals inc
  • Par pharmaceutical inc
  • L perrigo co
  • Ranbaxy pharmaceuticals inc
  • Torpharm inc
  • Watson laboratories inc
  • Wockhardt americas inc
  • Boehringer ingelheim
Packagers
Dosage forms
FormRouteStrength
Tabletoral75.0 mg
Tabletoral150 mg/1
Kit
Tabletoral75 mg/1
Tablet, film coatedoral150 mg/1
Tabletoral150 mg
Tabletoral300 mg
Tabletoral400 mg
Solutionoral15 mg/mL
Solutionoral150 mg/mL
Solutionoral75 mg/5mL
Syruporal15 mg/mL
Syruptopical15 mg/mL
Tabletoral300 mg/1
Tablet, film coatedoral300 mg/1
Tablet, film coatedoral75 mg/1
Capsuleoral150 mg/1
Capsuleoral300 mg/1
Injectionintramuscular; intravenous25 mg/mL
Solutionoral150 mg/10mL
Solutionoral15 mg
Tablet, coatedoral150 mg/1
Injection, solutionintramuscular; intravenous25 mg/mL
Liquidintramuscular; intravenous25 mg
Solutionintramuscular; intravenous25 mg
Tabletoral75 mg
Tablet, coatedoral75 mg/1
Capsuleoral150 mg
Capsuleoral300 mg
Prices
Unit descriptionCostUnit
Zantac 300 mg tablet7.96USD tablet
Ranitidine hcl powder5.2USD g
Zantac EFFERdose 25 mg Effervescent Tabs4.18USD tab
Zantac 25 efferdose tablet4.02USD tablet
Zantac 150 mg tablet3.11USD tablet
Ranitidine HCl 300 mg capsule2.85USD capsule
Ranitidine HCl 300 mg tablet2.79USD tablet
Ranitidine 300 mg tablet2.69USD tablet
Ranitidine hcl 25 mg/ml vial2.0USD ml
Zantac 25 mg/ml vial2.0USD ml
Ranitidine HCl 150 mg capsule1.58USD capsule
Zantac 25 mg/ml1.58USD ml
Ranitidine HCl 150 mg tablet1.54USD tablet
Ranitidine 150 mg tablet1.48USD tablet
Ranitidine 25 mg/ml1.26USD ml
Ranitidine HCl 15 mg/ml Syrup1.0USD ml
Ratio-Ranitidine 300 mg Tablet0.82USD tablet
Apo-Ranitidine 300 mg Tablet0.82USD tablet
Co Ranitidine 300 mg Tablet0.82USD tablet
Mylan-Ranitidine 300 mg Tablet0.82USD tablet
Nu-Ranit 300 mg Tablet0.82USD tablet
Pms-Ranitidine 300 mg Tablet0.82USD tablet
Ran-Ranitidine 300 mg Tablet0.82USD tablet
Zantac 15 mg/ml Syrup0.81USD ml
Zantac 75 tablet0.49USD tablet
Apo-Ranitidine 150 mg Tablet0.42USD tablet
Co Ranitidine 150 mg Tablet0.42USD tablet
Mylan-Ranitidine 150 mg Tablet0.42USD tablet
Nu-Ranit 150 mg Tablet0.42USD tablet
Pms-Ranitidine 150 mg Tablet0.42USD tablet
Ran-Ranitidine 150 mg Tablet0.42USD tablet
Ratio-Ranitidine 150 mg Tablet0.42USD tablet
Novo-Ranidine 300 mg Tablet0.38USD tablet
Phl-Ranitidine 300 mg Tablet0.38USD tablet
Sandoz Ranitidine 300 mg Tablet0.38USD tablet
Zantac 300 mg Tablet0.38USD tablet
Zantac 75 mg tablet0.28USD tablet
Wal-zan 75 mg tablet0.27USD tablet
Zantac 15 mg/ml Solution0.23USD ml
Ranitidine hcl 75 mg tablet0.22USD tablet
Sm acid reducer 75 mg tablet0.22USD tablet
Acid reducer 150 mg tablet0.2USD tablet
Wal-zan 75 tablet0.2USD tablet
Novo-Ranidine 150 mg Tablet0.19USD tablet
Phl-Ranitidine 150 mg Tablet0.19USD tablet
Sandoz Ranitidine 150 mg Tablet0.19USD tablet
Zantac 150 mg Tablet0.19USD tablet
CVS Pharmacy ranitidine 75 mg tablet0.15USD tablet
Apo-Ranitidine 15 mg/ml Solution0.12USD ml
Novo-Ranidine 15 mg/ml Solution0.12USD ml
Acid reducer 75 mg tablet0.11USD tablet
CVS Pharmacy acid reducer 75 mg tablet0.11USD tablet
Qc ranitidine 75 mg tablet0.07USD tablet
DrugBank does not sell nor buy drugs. Pricing information is supplied for informational purposes only.
Patents
Patent NumberPediatric ExtensionApprovedExpires (estimated)
CA1332610 No1994-10-182011-10-18Canada
US5098715 No1993-12-202010-12-20Us
US5102665 No1992-12-232009-12-23Us
Properties
StateSolid
Experimental Properties
PropertyValueSource
melting point69-70 °CPhysProp
water solubility24.7 mg/mLNot Available
logP0.27SANGSTER (1993)
Caco2 permeability-6.31ADME Research, USCD
Predicted Properties
PropertyValueSource
Water Solubility0.0795 mg/mLALOGPS
logP0.79ALOGPS
logP0.98ChemAxon
logS-3.6ALOGPS
pKa (Strongest Basic)8.08ChemAxon
Physiological Charge1ChemAxon
Hydrogen Acceptor Count5ChemAxon
Hydrogen Donor Count2ChemAxon
Polar Surface Area86.26 Å2ChemAxon
Rotatable Bond Count10ChemAxon
Refractivity95.15 m3·mol-1ChemAxon
Polarizability33.58 Å3ChemAxon
Number of Rings1ChemAxon
Bioavailability1ChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleYesChemAxon
MDDR-like RuleYesChemAxon
Spectra
Mass Spec (NIST)Not Available
Spectra
Spectrum TypeDescriptionSplash Key
LC-MS/MSLC-MS/MS Spectrum - Quattro_QQQ 10V, Positive (Annotated)splash10-sz0n000000-d0c73cd55f0c88b5292cView in MoNA
LC-MS/MSLC-MS/MS Spectrum - Quattro_QQQ 25V, Positive (Annotated)splash10-az10000000-72810aa2bdb337010c71View in MoNA
LC-MS/MSLC-MS/MS Spectrum - Quattro_QQQ 40V, Positive (Annotated)splash10-ez10000000-4984706aec6a10a3a701View in MoNA
LC-MS/MSLC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 10V, Negativesplash10-030z000000-3a9ffadb8ced05c4f2f1View in MoNA
LC-MS/MSLC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 20V, Negativesplash10-0z01000000-26410712c1d9fca3970fView in MoNA
LC-MS/MSLC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 30V, Negativesplash10-1z00000000-b8d8d8a38eb5ff79811dView in MoNA
LC-MS/MSLC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 40V, Negativesplash10-9z00000000-417be0cb4c8a324c3ae4View in MoNA
LC-MS/MSLC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 50V, Negativesplash10-lz00000000-ca80edf051507a622e91View in MoNA
LC-MS/MSLC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 10V, Positivesplash10-011z000000-e8f56e6282043759674eView in MoNA
LC-MS/MSLC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 20V, Positivesplash10-2zcd000000-aaee0f5a149286ba8834View in MoNA
LC-MS/MSLC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 30V, Positivesplash10-5z10000000-52e4e1bcfef85a6bafeaView in MoNA
LC-MS/MSLC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 40V, Positivesplash10-8z00000000-e412e77b79750d8bb513View in MoNA
LC-MS/MSLC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 50V, Positivesplash10-iz00000000-76d786153c89ecf65f8cView in MoNA
LC-MS/MSLC-MS/MS Spectrum - LC-ESI-IT (LC/MSD Trap XCT, Agilent Technologies) , Positivesplash10-1zd0000000-01f54848489d6a7b4da4View in MoNA
LC-MS/MSLC-MS/MS Spectrum - LC-ESI-IT (LC/MSD Trap XCT, Agilent Technologies) , Positivesplash10-1zt0000000-49b8e0b710b97f5d5da6View in MoNA
LC-MS/MSLC-MS/MS Spectrum - LC-ESI-IT (LC/MSD Trap XCT, Agilent Technologies) , Positivesplash10-0z20000000-cf634d229fba340e6e3bView in MoNA
LC-MS/MSLC-MS/MS Spectrum - LC-ESI-IT (LC/MSD Trap XCT, Agilent Technologies) , Positivesplash10-0z00000000-09008c251fc8dd33b8bfView in MoNA
LC-MS/MSLC-MS/MS Spectrum - LC-ESI-IT (LC/MSD Trap XCT, Agilent Technologies) , Positivesplash10-iz00000000-350ded3a1f334f8103b1View in MoNA
LC-MS/MSLC-MS/MS Spectrum - LC-ESI-IT (LC/MSD Trap XCT, Agilent Technologies) , Positivesplash10-2z00000000-14196f34248aa3cac7fcView in MoNA
LC-MS/MSLC-MS/MS Spectrum - LC-ESI-IT (LC/MSD Trap XCT, Agilent Technologies) , Positivesplash10-3z00000000-0a386c1d346e41534469View in MoNA
LC-MS/MSLC-MS/MS Spectrum - LC-ESI-IT (LC/MSD Trap XCT, Agilent Technologies) , Positivesplash10-1z00000000-4296a8171c03e3b2b689View in MoNA
1D NMR1H NMR SpectrumNot Available
2D NMR[1H,13C] 2D NMR SpectrumNot Available
References
Synthesis Reference

John W. Clitherow, “Intermediates in the preparation of ranitidine.” U.S. Patent US4413135, issued November, 1981.

US4413135
General ReferencesNot Available
External Links
ATC CodesA02BA02A02BA07
AHFS Codes
  • 56:28.12
PDB EntriesNot Available
FDA labelDownload (247 KB)
MSDSDownload (73.9 KB)
Interactions
Drug Interactions
Drug
AripiprazoleThe serum concentration of Aripiprazole can be increased when it is combined with Ranitidine.
AtazanavirThe serum concentration of Atazanavir can be decreased when it is combined with Ranitidine.
BosutinibThe serum concentration of Bosutinib can be decreased when it is combined with Ranitidine.
BupropionThe serum concentration of Ranitidine can be increased when it is combined with Bupropion.
CefditorenThe serum concentration of Cefditoren can be decreased when it is combined with Ranitidine.
CefpodoximeRanitidine can cause a decrease in the absorption of Cefpodoxime resulting in a reduced serum concentration and potentially a decrease in efficacy.
CefuroximeRanitidine can cause a decrease in the absorption of Cefuroxime resulting in a reduced serum concentration and potentially a decrease in efficacy.
ChlorpropamideThe serum concentration of Chlorpropamide can be increased when it is combined with Ranitidine.
CysteamineThe therapeutic efficacy of Cysteamine can be decreased when used in combination with Ranitidine.
DabrafenibThe serum concentration of Dabrafenib can be decreased when it is combined with Ranitidine.
DasatinibRanitidine can cause a decrease in the absorption of Dasatinib resulting in a reduced serum concentration and potentially a decrease in efficacy.
DelavirdineThe serum concentration of Delavirdine can be decreased when it is combined with Ranitidine.
DexmethylphenidateRanitidine can cause an increase in the absorption of Dexmethylphenidate resulting in an increased serum concentration and potentially a worsening of adverse effects.
DoxofyllineThe serum concentration of Doxofylline can be increased when it is combined with Ranitidine.
ErlotinibThe serum concentration of Erlotinib can be decreased when it is combined with Ranitidine.
FosamprenavirThe serum concentration of Fosamprenavir can be decreased when it is combined with Ranitidine.
GefitinibThe serum concentration of Gefitinib can be decreased when it is combined with Ranitidine.
GliclazideThe serum concentration of Gliclazide can be increased when it is combined with Ranitidine.
GlimepirideThe serum concentration of Glimepiride can be increased when it is combined with Ranitidine.
GlipizideThe serum concentration of Glipizide can be increased when it is combined with Ranitidine.
GlyburideThe serum concentration of Glyburide can be increased when it is combined with Ranitidine.
IndinavirThe serum concentration of Indinavir can be decreased when it is combined with Ranitidine.
Iron DextranRanitidine can cause a decrease in the absorption of Iron Dextran resulting in a reduced serum concentration and potentially a decrease in efficacy.
ItraconazoleThe serum concentration of Itraconazole can be decreased when it is combined with Ranitidine.
KetoconazoleThe serum concentration of Ketoconazole can be decreased when it is combined with Ranitidine.
LedipasvirThe serum concentration of Ledipasvir can be decreased when it is combined with Ranitidine.
LumacaftorThe serum concentration of Ranitidine can be decreased when it is combined with Lumacaftor.
MesalazineThe therapeutic efficacy of Mesalazine can be decreased when used in combination with Ranitidine.
MethylphenidateRanitidine can cause an increase in the absorption of Methylphenidate resulting in an increased serum concentration and potentially a worsening of adverse effects.
NelfinavirThe serum concentration of Nelfinavir can be decreased when it is combined with Ranitidine.
NilotinibThe serum concentration of Nilotinib can be decreased when it is combined with Ranitidine.
PazopanibThe serum concentration of Pazopanib can be decreased when it is combined with Ranitidine.
PosaconazoleThe serum concentration of Posaconazole can be decreased when it is combined with Ranitidine.
PrasugrelThe serum concentration of the active metabolites of Prasugrel can be reduced when Prasugrel is used in combination with Ranitidine resulting in a loss in efficacy.
ProcainamideThe serum concentration of Procainamide can be increased when it is combined with Ranitidine.
RanolazineThe serum concentration of Ranitidine can be increased when it is combined with Ranolazine.
RilpivirineThe serum concentration of Rilpivirine can be decreased when it is combined with Ranitidine.
RisedronateThe serum concentration of Risedronate can be increased when it is combined with Ranitidine.
SaquinavirThe serum concentration of Saquinavir can be increased when it is combined with Ranitidine.
TesmilifeneThe serum concentration of Ranitidine can be decreased when it is combined with Tesmilifene.
TizanidineThe serum concentration of Tizanidine can be increased when it is combined with Ranitidine.
TolazamideThe serum concentration of Tolazamide can be increased when it is combined with Ranitidine.
TolbutamideThe serum concentration of Tolbutamide can be increased when it is combined with Ranitidine.
VareniclineThe serum concentration of Varenicline can be increased when it is combined with Ranitidine.
VerapamilThe serum concentration of Ranitidine can be increased when it is combined with Verapamil.
WarfarinThe serum concentration of Warfarin can be increased when it is combined with Ranitidine.
Food Interactions
  • Avoid alcohol.
  • Avoid excessive quantities of coffee or tea (Caffeine).
  • Avoid milk, calcium containing dairy products, iron, antacids, or aluminum salts 2 hours before or 6 hours after using antacids while on this medication.
  • Take without regard to meals.

Targets

Kind
Protein
Organism
Human
Pharmacological action
yes
Actions
antagonist
General Function:
Histamine receptor activity
Specific Function:
The H2 subclass of histamine receptors mediates gastric acid secretion. Also appears to regulate gastrointestinal motility and intestinal secretion. Possible role in regulating cell growth and differentiation. The activity of this receptor is mediated by G proteins which activate adenylyl cyclase and, through a separate G protein-dependent mechanism, the phosphoinositide/protein kinase (PKC) si...
Gene Name:
HRH2
Uniprot ID:
P25021
Molecular Weight:
40097.65 Da
References
  1. Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. [PubMed:11752352 ]
  2. Pattichis K, Louca LL: Histamine, histamine H2-receptor antagonists, gastric acid secretion and ulcers: an overview. Drug Metabol Drug Interact. 1995;12(1):1-36. [PubMed:7554999 ]

Enzymes

Kind
Protein
Organism
Human
Pharmacological action
unknown
Actions
substrateinhibitor
General Function:
Oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
Specific Function:
Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics. Most active in catalyzing 2-hydroxylation. Caffeine is metabolized primarily by cytochrome CYP1A2 in the liver through an initial N...
Gene Name:
CYP1A2
Uniprot ID:
P05177
Molecular Weight:
58293.76 Da
References
  1. Preissner S, Kroll K, Dunkel M, Senger C, Goldsobel G, Kuzman D, Guenther S, Winnenburg R, Schroeder M, Preissner R: SuperCYP: a comprehensive database on Cytochrome P450 enzymes including a tool for analysis of CYP-drug interactions. Nucleic Acids Res. 2010 Jan;38(Database issue):D237-43. doi: 10.1093/nar/gkp970. Epub 2009 Nov 24. [PubMed:19934256 ]
Kind
Protein
Organism
Human
Pharmacological action
unknown
Actions
substrate
General Function:
Steroid hydroxylase activity
Specific Function:
Responsible for the metabolism of a number of therapeutic agents such as the anticonvulsant drug S-mephenytoin, omeprazole, proguanil, certain barbiturates, diazepam, propranolol, citalopram and imipramine.
Gene Name:
CYP2C19
Uniprot ID:
P33261
Molecular Weight:
55930.545 Da
References
  1. Preissner S, Kroll K, Dunkel M, Senger C, Goldsobel G, Kuzman D, Guenther S, Winnenburg R, Schroeder M, Preissner R: SuperCYP: a comprehensive database on Cytochrome P450 enzymes including a tool for analysis of CYP-drug interactions. Nucleic Acids Res. 2010 Jan;38(Database issue):D237-43. doi: 10.1093/nar/gkp970. Epub 2009 Nov 24. [PubMed:19934256 ]
Kind
Protein
Organism
Human
Pharmacological action
unknown
Actions
substrateinhibitor
General Function:
Steroid hydroxylase activity
Specific Function:
Responsible for the metabolism of many drugs and environmental chemicals that it oxidizes. It is involved in the metabolism of drugs such as antiarrhythmics, adrenoceptor antagonists, and tricyclic antidepressants.
Gene Name:
CYP2D6
Uniprot ID:
P10635
Molecular Weight:
55768.94 Da
References
  1. Preissner S, Kroll K, Dunkel M, Senger C, Goldsobel G, Kuzman D, Guenther S, Winnenburg R, Schroeder M, Preissner R: SuperCYP: a comprehensive database on Cytochrome P450 enzymes including a tool for analysis of CYP-drug interactions. Nucleic Acids Res. 2010 Jan;38(Database issue):D237-43. doi: 10.1093/nar/gkp970. Epub 2009 Nov 24. [PubMed:19934256 ]
  2. Drug Interactions: Cytochrome P450 Drug Interaction Table [Link]
Kind
Protein
Organism
Human
Pharmacological action
unknown
Actions
inhibitor
General Function:
Vitamin d3 25-hydroxylase activity
Specific Function:
Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It performs a variety of oxidation reactions (e.g. caffeine 8-oxidation, omeprazole sulphoxidation, midazolam 1'-hydroxylation and midazolam 4-hydroxylation) of structurally unrelated compounds, including steroids, fatty acids, and xenobiot...
Gene Name:
CYP3A4
Uniprot ID:
P08684
Molecular Weight:
57342.67 Da
References
  1. Preissner S, Kroll K, Dunkel M, Senger C, Goldsobel G, Kuzman D, Guenther S, Winnenburg R, Schroeder M, Preissner R: SuperCYP: a comprehensive database on Cytochrome P450 enzymes including a tool for analysis of CYP-drug interactions. Nucleic Acids Res. 2010 Jan;38(Database issue):D237-43. doi: 10.1093/nar/gkp970. Epub 2009 Nov 24. [PubMed:19934256 ]
Kind
Protein
Organism
Human
Pharmacological action
unknown
Actions
inhibitor
General Function:
Oxygen binding
Specific Function:
Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics.
Gene Name:
CYP3A5
Uniprot ID:
P20815
Molecular Weight:
57108.065 Da
References
  1. Preissner S, Kroll K, Dunkel M, Senger C, Goldsobel G, Kuzman D, Guenther S, Winnenburg R, Schroeder M, Preissner R: SuperCYP: a comprehensive database on Cytochrome P450 enzymes including a tool for analysis of CYP-drug interactions. Nucleic Acids Res. 2010 Jan;38(Database issue):D237-43. doi: 10.1093/nar/gkp970. Epub 2009 Nov 24. [PubMed:19934256 ]

Transporters

Kind
Protein
Organism
Human
Pharmacological action
unknown
Actions
inhibitor
General Function:
Secondary active organic cation transmembrane transporter activity
Specific Function:
Translocates a broad array of organic cations with various structures and molecular weights including the model compounds 1-methyl-4-phenylpyridinium (MPP), tetraethylammonium (TEA), N-1-methylnicotinamide (NMN), 4-(4-(dimethylamino)styryl)-N-methylpyridinium (ASP), the endogenous compounds choline, guanidine, histamine, epinephrine, adrenaline, noradrenaline and dopamine, and the drugs quinine...
Gene Name:
SLC22A1
Uniprot ID:
O15245
Molecular Weight:
61153.345 Da
References
  1. Bednarczyk D, Ekins S, Wikel JH, Wright SH: Influence of molecular structure on substrate binding to the human organic cation transporter, hOCT1. Mol Pharmacol. 2003 Mar;63(3):489-98. [PubMed:12606755 ]
Kind
Protein
Organism
Human
Pharmacological action
unknown
Actions
substrateinhibitor
General Function:
Xenobiotic-transporting atpase activity
Specific Function:
Energy-dependent efflux pump responsible for decreased drug accumulation in multidrug-resistant cells.
Gene Name:
ABCB1
Uniprot ID:
P08183
Molecular Weight:
141477.255 Da
References
  1. Lentz KA, Polli JW, Wring SA, Humphreys JE, Polli JE: Influence of passive permeability on apparent P-glycoprotein kinetics. Pharm Res. 2000 Dec;17(12):1456-60. [PubMed:11303953 ]
  2. Schwab D, Fischer H, Tabatabaei A, Poli S, Huwyler J: Comparison of in vitro P-glycoprotein screening assays: recommendations for their use in drug discovery. J Med Chem. 2003 Apr 24;46(9):1716-25. [PubMed:12699389 ]
  3. Troutman MD, Thakker DR: Novel experimental parameters to quantify the modulation of absorptive and secretory transport of compounds by P-glycoprotein in cell culture models of intestinal epithelium. Pharm Res. 2003 Aug;20(8):1210-24. [PubMed:12948019 ]
  4. Faassen F, Vogel G, Spanings H, Vromans H: Caco-2 permeability, P-glycoprotein transport ratios and brain penetration of heterocyclic drugs. Int J Pharm. 2003 Sep 16;263(1-2):113-22. [PubMed:12954186 ]
Kind
Protein
Organism
Human
Pharmacological action
unknown
Actions
substrate
General Function:
Sodium-independent organic anion transmembrane transporter activity
Specific Function:
Plays an important role in the excretion/detoxification of endogenous and exogenous organic anions, especially from the brain and kidney. Involved in the transport basolateral of steviol, fexofenadine. Transports benzylpenicillin (PCG), estrone-3-sulfate (E1S), cimetidine (CMD), 2,4-dichloro-phenoxyacetate (2,4-D), p-amino-hippurate (PAH), acyclovir (ACV) and ochratoxin (OTA).
Gene Name:
SLC22A8
Uniprot ID:
Q8TCC7
Molecular Weight:
59855.585 Da
References
  1. Tahara H, Kusuhara H, Chida M, Fuse E, Sugiyama Y: Is the monkey an appropriate animal model to examine drug-drug interactions involving renal clearance? Effect of probenecid on the renal elimination of H2 receptor antagonists. J Pharmacol Exp Ther. 2006 Mar;316(3):1187-94. Epub 2005 Nov 16. [PubMed:16291876 ]
Comments
comments powered by Disqus
Drug created on June 13, 2005 07:24 / Updated on September 16, 2013 17:12